Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helfand

Showing results (561-570 of 657) with videos related to

Pageof 66
Sort By:
Journal of Clinical Epidemiology|May 22, 2012
GRADE guidelines: 12. Preparing summary of findings tables-binary outcomesGordon H Guyatt, Andrew D Oxman, Nancy Santesso, et al.
Neurourology and Urodynamics|July 16, 2024
The AUA/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladderAnne P Cameron, Doreen E Chung, Elodi J Dielubanza, et al.
The Journal of Urology|April 23, 2024
The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive BladderAnne P Cameron, Doreen E Chung, Elodi J Dielubanza, et al.
Journal of Geriatric Psychiatry and Neurology|May 17, 2025
Better Assessment of Illness Study (BASIL) II for Delirium Severity: Study Design, Variables, and MethodsTammy T Hshieh, Benjamin A Chapin, Wingyun Mak, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2022
Sirt6 regulates lifespan in <i>Drosophila melanogaster</i>Jackson R Taylor, Jason G Wood, Evan Mizerak, et al.
European Urology|July 6, 2023
Diagnostic Performance and Safety of Positron Emission Tomography with <sup>18</sup>F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE)Devaki Shilpa Surasi, Matthias Eiber, Tobias Maurer, et al.
Cancer Research|February 28, 2016
Mutational Landscape of Aggressive Prostate Tumors in African American MenKarla J Lindquist, Pamela L Paris, Thomas J Hoffmann, et al.
Frontiers in Immunology|July 22, 2025
Immune cell single-cell RNA sequencing analyses link an age-associated T cell subset to symptomatic benign prostatic hyperplasiaMeaghan M Broman, Nadia A Lanman, Renee E Vickman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2009
Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomyQiang Zhang, Brian T Helfand, Thomas L Jang, et al.
The Prostate|August 18, 2020
Feasibility and performance of a novel probe panel to detect somatic DNA copy number alterations in clinical specimens for predicting prostate cancer progressionWennuan Liu, Jun Hou, Jacqueline Petkewicz, et al.
Pageof 66

Showing results (561-570 of 657) with videos related to

Sort By:
Pageof 66
Journal of Clinical Epidemiology|May 22, 2012
GRADE guidelines: 12. Preparing summary of findings tables-binary outcomesGordon H Guyatt, Andrew D Oxman, Nancy Santesso, et al.
Neurourology and Urodynamics|July 16, 2024
The AUA/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladderAnne P Cameron, Doreen E Chung, Elodi J Dielubanza, et al.
The Journal of Urology|April 23, 2024
The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive BladderAnne P Cameron, Doreen E Chung, Elodi J Dielubanza, et al.
Journal of Geriatric Psychiatry and Neurology|May 17, 2025
Better Assessment of Illness Study (BASIL) II for Delirium Severity: Study Design, Variables, and MethodsTammy T Hshieh, Benjamin A Chapin, Wingyun Mak, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2022
Sirt6 regulates lifespan in <i>Drosophila melanogaster</i>Jackson R Taylor, Jason G Wood, Evan Mizerak, et al.
European Urology|July 6, 2023
Diagnostic Performance and Safety of Positron Emission Tomography with <sup>18</sup>F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE)Devaki Shilpa Surasi, Matthias Eiber, Tobias Maurer, et al.
Cancer Research|February 28, 2016
Mutational Landscape of Aggressive Prostate Tumors in African American MenKarla J Lindquist, Pamela L Paris, Thomas J Hoffmann, et al.
Frontiers in Immunology|July 22, 2025
Immune cell single-cell RNA sequencing analyses link an age-associated T cell subset to symptomatic benign prostatic hyperplasiaMeaghan M Broman, Nadia A Lanman, Renee E Vickman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2009
Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomyQiang Zhang, Brian T Helfand, Thomas L Jang, et al.
The Prostate|August 18, 2020
Feasibility and performance of a novel probe panel to detect somatic DNA copy number alterations in clinical specimens for predicting prostate cancer progressionWennuan Liu, Jun Hou, Jacqueline Petkewicz, et al.
Pageof 66